PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 98 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $46,000 | – | 8,300 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 3,196,527 | $12,083,000 | 1.37% |
| GREAT POINT PARTNERS LLC | 1,550,000 | $5,859,000 | 1.30% |
| Lynx1 Capital Management LP | 383,266 | $1,449,000 | 1.26% |
| BVF INC/IL | 5,328,239 | $20,141,000 | 0.73% |
| Cutter & CO Brokerage, Inc. | 394,800 | $1,492,000 | 0.41% |
| Soleus Capital Management, L.P. | 687,412 | $2,598,000 | 0.26% |
| WEALTH EFFECTS LLC | 87,300 | $330,000 | 0.14% |
| Woodline Partners LP | 2,463,641 | $9,313,000 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $3,887,000 | 0.11% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 26,700 | $101,000 | 0.10% |